Credit Suisse Reaffirms Their Hold Rating on Elanco Animal Health Inc (ELAN)

By Jason Carr

In a report released yesterday, Erin Wright from Credit Suisse maintained a Hold rating on Elanco Animal Health Inc (ELANResearch Report), with a price target of $33. The company’s shares closed yesterday at $31.83.

According to TipRanks.com, Wright is ranked #632 out of 5103 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Elanco Animal Health Inc with a $34.88 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $37.61 and a one-year low of $28.85. Currently, Elanco Animal Health Inc has an average volume of 1.22M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It operates through the following categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.